Oragenics, Inc.
corporate_fare Company Profile
Oragenics, Inc. (NYSE:OGEN) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 1 item for OGEN at importance 7 or higher on its 1–10 market-impact scale. Its most recent item scored 7 or higher is dated 2026-11-12, rated 9/10. Recent SEC coverage for OGEN spans 10-Q.
Recent high-impact activity:
- Oragenics 10-Q: Going Concern Doubt, ONP-002 Enrollment Paused, $2.2M Cash Lasts to Year-End
Financial Snapshot
Short Interest & Short Volume
40.07 days to coverFINRA reported short interest of 835,778 shares in OGEN as of the October 30, 2026 settlement, a 0.1% decrease from the prior period — about 40.1 days to cover at its recent average daily volume. On November 20, 2026, 14.7% of OGEN volume reported to FINRA trade-reporting facilities was marked short.
Daily short sale volume covers trades reported to FINRA trade-reporting facilities and is not the same as short interest (bi-monthly reported positions). Source: FINRA — FINRA is the owner and source of this short interest and short sale volume data; it may not be redistributed.